《2019年国际共识声明:远端胆管狭窄的内镜管理》解读

朱亮; 陈幼祥

doi:10.3969/j.issn.1001-5256.2020.06.011

《2019年国际共识声明:远端胆管狭窄的内镜管理》解读

DOI: 10.3969/j.issn.1001-5256.2020.06.011

朱亮,
陈幼祥

南昌大学第一附属医院消化内科

基金项目:

江西省教育厅科学技术研究重点项目(GJJ170006)；江西省卫健委科技计划项目(20195082)

详细信息

中图分类号: R657.46
计量
- 文章访问数: 312
- HTML全文浏览量: 39
- PDF下载量: 76
- 被引次数: 0
出版历程
- 出版日期: 2020-06-20

Interpretation of International consensus statement for endoscopic management of distal biliary stricture( 2019)

Research funding:

摘要

摘要:
远端胆管狭窄是临床常见的胆管病变,可由良恶性疾病所致。尽管目前内镜技术已成为治疗远端胆管狭窄的主要手段,但对其仍缺乏全面认识。基于此,2019年亚洲胆胰疾病介入治疗小组发布了《远端胆管狭窄内镜管理的国际共识意见》,从诊断、治疗、随访等多个维度阐述了远端胆管狭窄内镜管理的相关共识意见,笔者对其中一些重点内容进行梳理及解读,以期为临床实践提供参考。
- 胆管疾病 /
- 内窥镜检查 /
- 共识
Abstract:
Distal biliary stricture is a biliary lesion commonly seen in clinical practice and can be caused by benign and malignant diseases.Although endoscopic technique has become a major treatment method for distal biliary stricture,there is still a lack of comprehensive understanding of this condition. Therefore,Asian Group of Interventional Treatment of Pancreaticobiliary Diseases published International consensus statement for endoscopic management of distal biliary stricture in 2019,which elaborates on the consensus statement on the endoscopic management of distal biliary stricture from the aspects of diagnosis,treatment,and follow-up. This article makes an interpretation of some key points in the above consensus statement,in order to provide a reference for clinical practice.
- bile duct diseases /
- endoscopy /
- consensus

HTML全文

参考文献(29)

[1] NAKAI Y,ISAYAMA H,WANG HP,et al. International consensus statements for endoscopic management of distal biliary stricture[J]. J Gastroenterol Hepatol,2019.[Online ahead of print]

[2] SHEKELLE PG,WOOLF SH,ECCLES M,et al. Developing clinical guidelines[J]. West J Med,1999,170(6):348-351.

[3] NAVANEETHAN U,NJEI B,VENKATESH PG,et al. Endoscopic ultrasound in the diagnosis of cholangiocarcinoma as the etiology of biliary strictures:A systematic review and meta-analysis[J].Gastroenterol Rep(Oxf),2015,3(3):209-215.

[4] LEE YN,MOON JH,CHOI HJ,et al. Diagnostic approach using ERCP-guided transpapillary forceps biopsy or EUSguided fine-needle aspiration biopsy according to the nature of stricture segment for patients with suspected malignant biliary stricture[J]. Cancer Med,2017,6(3):582-590.

[5] RANNEY N,PHADNIS M,TREVINO J,et al. Impact of biliary stents on EUS-guided FNA of pancreatic mass lesions[J].Gastrointest Endosc,2012,76(1):76-83.

[6] DRAGANOV PV,CHAUHAN S,WAGH MS,et al. Diagnostic accuracy of conventional and cholangioscopy-guided sampling of indeterminate biliary lesions at the time of ERCP:A prospective,long-term follow-up study[J]. Gastrointest Endosc,2012,75(2):347-353.

[7] TALREJA JP,SETHI A,JAMIDAR PA,et al. Interpretation of probe-based confocal laser endomicroscopy of indeterminate biliary strictures:Is there any interobserver agreement?[J].Dig Dis Sci,2012,57(12):3299-3302.

[8] HALTTUNEN J,MEISNER S,AABAKKEN L,et al. Difficult cannulation as defined by a prospective study of the Scandinavian Association for Digestive Endoscopy(SADE)in 907 ERCPs[J].Scand J Gastroenterol,2014,49(6):752-758.

[9] HU B,SUN B,CAI Q,et al. Asia-Pacific consensus guidelines for endoscopic management of benign biliary strictures[J]. Gastrointest Endosc,2017,86(1):44-58.

[10] KHAN MA,BARON TH,KAMAL F,et al. Efficacy of self-expandable metal stents in management of benign biliary strictures and comparison with multiple plastic stents:A metaanalysis[J]. Endoscopy,2017,49(7):682-694.

[11] van der GAAG NA,RAUWS EA,van EIJCK CH,et al. Preoperative biliary drainage for cancer of the head of the pancreas[J]. N Engl J Med,2010,362(2):129-137.

[12] TOL JA,VAN HOOFT JE,TIMMER R,et al. Metal or plastic stents for preoperative biliary drainage in resectable pancreatic cancer[J]. Gut,2016,65(12):1981-1987.

[13] SONG TJ,LEE JH,LEE SS,et al. Metal versus plastic stents for drainage of malignant biliary obstruction before primary surgical resection[J]. Gastrointest Endosc,2016,84(5):814-821.

[14] ISAYAMA H,KOMATSU Y,TSUJINO T,et al. A prospective randomised study of“covered”versus“uncovered”diamond stents for the management of distal malignant biliary obstruction[J]. Gut,2004,53(5):729-734.

[15] KROKIDIS M,FANELLI F,ORGERA G,et al. Percutaneous palliation of pancreatic head cancer:Randomized comparison of e PTFE/FEP-covered versus uncovered nitinol biliary stents[J]. Cardiovasc Intervent Radiol,2011,34(2):352-361.

[16] KITANO M,YAMASHITA Y,TANAKA K,et al. Covered selfexpandable metal stents with an anti-migration system improve patency duration without increased complications compared with uncovered stents for distal biliary obstruction caused by pancreatic carcinoma:A randomized multicenter trial[J]. Am J Gastroenterol,2013,108(11):1713-1722.

[17] NAKAI Y,ISAYAMA H,KAWABE T,et al. Efficacy and safety of metallic stents in patients with unresectable pancreatic cancer receiving gemcitabine[J]. Pancreas,2008,37(4):405-410.

[18] NAKAI Y,HAMADA T,ISAYAMA H,et al. Endoscopic management of combined malignant biliary and gastric outlet obstruction[J]. Dig Endosc,2017,29(1):16-25.

[19] HAMADA T,ISAYAMA H,NAKAI Y,et al. Transmural biliary drainage can be an alternative to transpapillary drainage in patients with an indwelling duodenal stent[J]. Dig Dis Sci,2014,59(8):1931-1938.

[20] OGURA T,CHIBA Y,MASUDA D,et al. Comparison of the clinical impact of endoscopic ultrasound-guided choledochoduodenostomy and hepaticogastrostomy for bile duct obstruction with duodenal obstruction[J]. Endoscopy,2016,48(2):156-163.

[21] KAHALEH M,MISHRA R,SHAMI VM,et al. Unresectable cholangiocarcinoma:Comparison of survival in biliary stenting alone versus stenting with photodynamic therapy[J]. Clin Gastroenterol Hepatol,2008,6(3):290-297.

[22] FIGUEROA-BAROJAS P,BAKHRU MR,HABIB NA,et al.Safety and efficacy of radiofrequency ablation in the management of unresectable bile duct and pancreatic cancer:A novel palliation technique[J]. J Oncol,2013,2013:910897.

[23] STRAND DS,COSGROVE ND,PATRIE JT,et al. ERCP-directed radiofrequency ablation and photodynamic therapy are associated with comparable survival in the treatment of unresectable cholangiocarcinoma[J]. Gastrointest Endosc,2014,80(5):794-804.

[24] DOLAK W,SCHREIBER F,SCHWAIGHOFER H,et al. Endoscopic radiofrequency ablation for malignant biliary obstruction:A nationwide retrospective study of 84 consecutive applications[J]. Surg Endosc,2014,28(3):854-860.

[25] YU H,MIAO L. Biliary stenting for cholangiocarcinoma:An update[J]. World Chin J Dig,2014,22(5):648-653.(in Chinese)于泓，缪林．胆管癌支架治疗的现状及进展[J]．世界华人消化杂志，2014,22(5):648-653.

[26] LEE DK,KIM HS,KIM KS,et al. The effect on porcine bile duct of a metallic stent covered with a paclitaxel-incorporated membrane[J]. Gastrointest Endosc,2005,61(2):296-301.

[27] KALINOWSKI M,ALFKE H,KLEB B,et al. Paclitaxel inhibits proliferation of cell lines responsible for metal stent obstruction:Possible topical application in malignant bile duct obstructions[J]. Invest Radiol,2002,37(7):399-404.

[28] SONG TJ,LEE SS,YUN SC,et al. Paclitaxel-eluting covered metal stents versus covered metal stents for distal malignant biliary obstruction:A prospective comparative pilot study[J]. Gastrointest Endosc,2011,73(4):727-733.

[29] KIM DH,JEONG YI,CHUNG CW,et al. Preclinical evaluation of sorafenib-eluting stent for suppression of human cholangiocarcinoma cells[J]. Int J Nanomedicine,2013,8:1697-1711.

施引文献

资源附件(0)

访问统计